Indian Journal of Vascular and Endovascular Surgery

ORIGINAL ARTICLE
Year
: 2022  |  Volume : 9  |  Issue : 2  |  Page : 145--150

Indian venaseal Experience study – Outcomes of nonthermal and nontumescent endovenous glue ablation for treatment of truncal reflux in varicose vein disease: An Indian perspective


Rutvij Asitkumar Shah, Varinder S Bedi, Ajay R Yadav, Sandeep Agarwal, Ambarish Satwik, Apurva Srivastava, Nikhil Vilas Chaudhari 
 Department of Vascular Surgery, Insitute of Vascular and Endovascular Sciences, Sir Ganga Ram Hospital, New Delhi, India

Correspondence Address:
Rutvij Asitkumar Shah
Department of Vascular Surgery, Insitute of Vascular and Endovascular Sciences, Sir Ganga Ram Hospital, New Delhi
India

Background: Varicose veins is a common disease in nearly 37.25% of the Indian population significantly affecting the quality of life. Endovenous thermal ablation has been the first-line treatment for superficial venous reflux. A new technique, available now, is nonthermal nontumescent vein sealing system (VenaSeal™), which comprises endovenous delivery of cyanoacrylate tissue adhesive into the vein causing obliteration of lumen and has shown better results in terms of safety and efficacy. Being a new modality, only handful of institutes across India perform this procedure and there is a scarcity of Indian data on its outcomes. Aims and Objectives: To evaluate the outcomes of VenaSeal™ glue ablation in terms of vein occlusion rates and improvement in Venous Clinical Severity Score (VCSS). Materials and Methods: Single-centre prospective study of fifty patients over 1 year and 4 months with 3- and 6-month follow-up. Results: The study showed the mean age of the study group to be 43.8 years and the majority (90%) had an early varicose vein (C2/C3) disease. The average length of vein treated per limb was 89.1 cm, and the average glue used per limb was 2.95 ml. All patients showed improvement in VCSS score from preoperative average of 2.6 ± 1.4 to 0.32 ± 0.19 (P < 0.0001, n = 89) with target vein occlusion rate of 100% at 3 months and 97.75% at 6 months. Conclusion: Thus, VenaSeal™ glue ablation procedure is a promising and effective modality for the treatment of varicose veins with excellent treatment success rates, minimal complications, and maximum patient acceptability. It is a feasible Out patient department (OPD) based procedure.


How to cite this article:
Shah RA, Bedi VS, Yadav AR, Agarwal S, Satwik A, Srivastava A, Chaudhari NV. Indian venaseal Experience study – Outcomes of nonthermal and nontumescent endovenous glue ablation for treatment of truncal reflux in varicose vein disease: An Indian perspective.Indian J Vasc Endovasc Surg 2022;9:145-150


How to cite this URL:
Shah RA, Bedi VS, Yadav AR, Agarwal S, Satwik A, Srivastava A, Chaudhari NV. Indian venaseal Experience study – Outcomes of nonthermal and nontumescent endovenous glue ablation for treatment of truncal reflux in varicose vein disease: An Indian perspective. Indian J Vasc Endovasc Surg [serial online] 2022 [cited 2022 Jul 3 ];9:145-150
Available from: https://www.indjvascsurg.org/article.asp?issn=0972-0820;year=2022;volume=9;issue=2;spage=145;epage=150;aulast=Shah;type=0